Cleerly Ischemia
Payments companies reported to CMS as associated with Cleerly Ischemia. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cleerly Ischemia, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cleerly Ischemia
These are the largest totals companies reported as associated with Cleerly Ischemia. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Michael Turner | Lake Charles, LA | Cardiovascular Disease | $1,157.56 |
| Matthew Budoff | Torrance, CA | Cardiovascular Disease | $627.65 |
| Asif Ali | Houston, TX | Cardiovascular Disease | $601.79 |
| Amro Alsaid | Danville, PA | Cardiovascular Disease | $589.03 |
| Alexander Balaez | Miami, FL | Physician Assistant | $580.42 |
| Nicholas Macpherson | Dallas, TX | Cardiovascular Disease | $578.31 |
| Tony Das | Dallas, TX | Interventional Cardiology | $559.36 |
| Veronica Bellumio | Miami, FL | Family | $555.42 |
| Yale Pollak | Boca Raton, FL | Diagnostic Radiology | $531.99 |
| Kanae Mukai | Salinas, CA | Cardiovascular Disease | $496.38 |
Prescribed Cleerly Ischemia?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.